动态对比增强3T MR成像用于眼眶病变定性的诊断效能:一项大型前瞻性研究验证
该前瞻性单中心研究纳入131例术前行3T MR成像的眼眶病变患者,评估动态对比增强MRI鉴别恶性与良性肿瘤的诊断效能。最佳多变量模型联合DCE参数、ADC和形态学特征,AUC为0.81(95%CI 0.67-0.96),敏感度0.82(95%CI 0.55-1),特异度0.81(95%CI 0.65-0.96)。结论认为3T DCE-MR成像对眼眶病变定性有价值,可为形态学成像和DWI提供补充信息。
要点
- 恶性眼眶病变的Ktrans中位数(1.1 minute-1)和Kep中位数(2.1 minute-1)均高于良性病变(分别为0.65 minute-1和1.1 minute-1)。
- 恶性病变Ktrans四分位距(0.81 minute-1)高于良性病变(0.65 minute-1),P=.009。
- 联合DCE参数、ADC和形态学的最佳多变量模型鉴别恶性与良性病变AUC为0.81。
核心结论
- 3T动态对比增强MR成像似乎对眼眶病变定性有价值,可为形态学成像和DWI提供补充信息。
研究设计与样本
- 经机构审查委员会批准的前瞻性单中心研究,2015年12月至2021年5月纳入131例术前接受3T MR成像的眼眶病变患者;由2名对全部数据设盲的阅片者评估形态学、扩散加权和动态对比增强MR图像,以活检或手术组织学分析为参考标准。
关键影像表现/征象
- 恶性病变Ktrans中位数1.1 minute-1高于良性病变0.65 minute-1(P=.03)。
- 恶性病变Kep中位数2.1 minute-1高于良性病变1.1 minute-1(P=.01)。
- 恶性病变Ktrans四分位距0.81 minute-1高于良性病变0.65 minute-1(P=.009)。
诊断标准与关键数值
- 最佳多变量模型(纳入DCE成像参数、ADC和形态学)鉴别恶性与良性病变的AUC为0.81(95%CI 0.67-0.96)。
- 最佳多变量模型敏感度为0.82(95%CI 0.55-1),特异度为0.81(95%CI 0.65-0.96)。
临床应用与阅片要点
- 3T DCE-MR成像可提供补充于形态学成像和DWI的信息,用于眼眶病变良恶性鉴别。
- 阅片时可关注Ktrans、Kep中位数及Ktrans四分位距等DCE定量参数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Orbital lesions are rare but serious. Their characterization remains challenging. Diagnosis is based on biopsy or surgery, which implies functional risks. It is necessary to develop noninvasive diagnostic tools. The goal of this study was to evaluate the diagnostic performance of dynamic contrast-enhanced MR imaging at 3T when distinguishing malignant from benign orbital tumors on a large prospective cohort.
MATERIALS AND METHODS: This institutional review board-approved prospective single-center study enrolled participants presenting with an orbital lesion undergoing a 3T MR imaging before surgery from December 2015 to May 2021. Morphologic, diffusion-weighted, and dynamic contrast-enhanced MR images were assessed by 2 readers blinded to all data. Univariable and multivariable analyses were performed. To assess diagnostic performance, we used the following metrics: area under the curve, sensitivity, and specificity. Histologic analysis, obtained through biopsy or surgery, served as the criterion standard for determining the benign or malignant status of the tumor.
RESULTS: One hundred thirty-one subjects (66/131 [50%] women and 65/131 [50%] men; mean age, 52 [SD, 17.1] years; range, 19-88 years) were enrolled. Ninety of 131 (69%) had a benign lesion, and 41/131 (31%) had a malignant lesion. Univariable analysis showed a higher median of transfer constant from blood plasma to the interstitial environment (K trans) and of transfer constant from the interstitial environment to the blood plasma (minute-1) (Kep) and a higher interquartile range of K trans in malignant-versus-benign lesions (1.1 minute-1 versus 0.65 minute-1, P = .03; 2.1 minute-1 versus 1.1 minute-1, P = .01; 0.81 minute-1 versus 0.65 minute-1, P = .009, respectively). The best-performing multivariable model in distinguishing malignant-versus-benign lesions included parameters from dynamic contrast-enhanced imaging, ADC, and morphology and reached an area under the curve of 0.81 (95% CI, 0.67-0.96), a sensitivity of 0.82 (95% CI, 0.55-1), and a specificity of 0.81 (95% CI, 0.65-0.96).
CONCLUSIONS: Dynamic contrast-enhanced MR imaging at 3T appears valuable when characterizing orbital lesions and provides complementary information to morphologic imaging and DWI.
引用
- O'Shaughnessy E, Cossec CL, Mambour N, et al. Diagnostic Performance of Dynamic Contrast-Enhanced 3T MR Imaging for Characterization of Orbital Lesions: Validation in a Large Prospective Study. AJNR Am J Neuroradiol. 2024. PMID: 38453407. doi:10.3174/ajnr.A8131
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。